BUSINESSCNBC-TV18 Markets · 20 hours agoLive
Torrent Pharma Q2 Results: Net profit declines despite 51% revenue growth; misses estimates
Reported by CNBC-TV18 Markets, not nibnow. We are not the publisher of this story, only the source is.
WHY IT MATTERS
The company’s profit fell even though revenue jumped sharply, signaling potential cost or margin pressures that could affect investors and shareholders.
WHAT HAPPENED
Torrent Pharmaceuticals reported a 9.6% YoY decline in Q2 FY27 net profit to ₹534 crore, while revenue grew 50.8% to ₹4,979 crore. EBITDA rose 54.1% to ₹1,583 crore, with the margin improving to 32.33%, although both EBITDA and net profit missed poll estimates.
KEY CONTEXT
Torrent Pharmaceuticals is a major Indian drugmaker; analysts watch its earnings and margins to gauge the health of the domestic pharma sector.
WHAT TO WATCH
- •Look for the company’s guidance for the next quarter or full‑year earnings
- •Monitor analyst updates or revisions to profit estimates
- •Watch for any statements on cost controls or pricing strategy
Text size
READ IN YOUR LENS
UPSCMarketsFounder